IL-5 in asthma

被引：3
作者：
Chung, KF [1 ]
van Rensen, E [1 ]
Stirling, R [1 ]
Barnes, PJ [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Natl Heart & Lung Inst, Dept Thorac Med, London SW3 6LY, England
来源：
THORAX | 2002年 / 57卷 / 08期
关键词：
D O I：
10.1136/thorax.57.8.751
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：751 / 751
页数：1
相关论文
共 50 条
[21]   Serum IFN-γ, IL-4, and IL-5 levels in acute asthma [J].
Woodruff, PG ;
Tollerud, D ;
Nadel, ES ;
Camargo, CA ;
Gillette, M ;
Shapiro, N ;
Griffey, R ;
Guevarra, L ;
Hanrahan, JP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) :A509-A509
[22]   Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD [J].
Drick, Nora ;
Fuge, Jan ;
Seeliger, Benjamin ;
Speth, Milan ;
Vogel-Claussen, Jens ;
Welte, Tobias ;
Suhling, Hendrik .
ERJ OPEN RESEARCH, 2022, 8 (04)
[23]   Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma [J].
Drick, Nora ;
Milger, Katrin ;
Seeliger, Benjamin ;
Fuge, Jan ;
Korn, Stephanie ;
Buhl, Roland ;
Schuhmann, Maren ;
Herth, Felix ;
Kendziora, Benjamin ;
Behr, Juergen ;
Kneidinger, Nikolaus ;
Bergmann, Karl-Christian ;
Taube, Christian ;
Welte, Tobias ;
Suhling, Hendrik .
JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 :605-614
[24]   Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma [J].
Matucci, Andrea ;
Maggi, Enrico ;
Vultaggio, Alessandra .
RESPIRATORY MEDICINE, 2019, 160
[25]   IL-5 Receptor Subunit Alpha Expression As A Possible Biomarker In Asthma [J].
Elena Perez, Sandra ;
Heredero Jung, David ;
Garcia Sanchez, Asuncion ;
Estravis, Miguel ;
Martin, Maria ;
Munoz Bellido, Francisco ;
Isidoro Garcia, Maria ;
Sanz, Catalina ;
Davila, Ignacio .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) :AB245-AB245
[26]   THE COST-EFFECTIVENESS OF IL-5 INHIBITORS FOR PERSONS WITH EOSINOPHILIC ASTHMA [J].
Jimenez, J. ;
Malone, D. .
VALUE IN HEALTH, 2019, 22 :S354-S354
[27]   Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update [J].
Walsh, Garry M. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (02) :143-149
[28]   Association of abdominal visceral adiposity with sputum IL-5 levels in asthma [J].
Goudarzi, Houman ;
Kimura, Hirokazu ;
Makita, Hironi ;
Abe, Yuki ;
Oguma, Akira ;
Sato, Michiko ;
Matsumoto, Munehiro ;
Takei, Nozomu ;
Kimura, Hiroki ;
Shimizu, Kaoruko ;
Suzuki, Masaru ;
Ito, Yoichi M. ;
Nishimura, Masaharu ;
Konno, Satoshi .
ALLERGOLOGY INTERNATIONAL, 2022, 71 (01) :137-139
[29]   IL-5 and eosinophilia [J].
Takatsu, Kiyoshi ;
Nakajima, Hiroshi .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (03) :288-294
[30]   Basophil activation test and serum IL-5 as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs [J].
Caruso, C. ;
Colantuono, S. ;
Tolusso, B. ;
Di Mario, C. ;
Pentassuglia, A. ;
Rumi, G. ;
Gremese, E. ;
Romano, A. ;
Gasbarrini, A. .
ALLERGY, 2020, 75 :398-398
12345